Panagiotis Iliakis
Panagiotis Iliakis is an expert in Cardiology at Geniko Nosokomeio Athinon "Ippokrateio" (Greece). Panagiotis Iliakis has authored 173 publications, the most recent in 2026. SLR score: 443 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Biochemistry - Nutrition - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2017 - 2026
Number : 173
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Non-Invasive Assessment of Coronary Microvascular Dysfunction: From Flow Quantification to Clinical Decision Making. PMID 42942485 — research design, blood, clinical decision-making, tomography, positron-emission tomography, stress, physiological, decision making, echocardiography | Medicina (Kaunas) | 2026 | 0 |
| Association Between Diet Quality and 20-Year Heart Failure Incidence: Findings from the ATTICA Cohort Study (2002-2022). PMID 42884729 — incidence, heart failure, heart, cohort studies, diet, food, dietary patterns | Nutrients | 2026 | 0 |
| Post-treatment risks of transcatheter aortic valve implantation: should we be increasing preventative measures? PMID 42870459 — endocarditis, aortic valve, transcatheter aortic valve replacement, therapeutics | Expert Rev Cardiovasc Ther | 2026 | 0 |
| The Role of Soluble Suppression of Tumorigenicity-2 and Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Scoping Review of the Literature. PMID 42859718 — galectins, fibrosis, heart failure, heart, heart failure, diastolic, galectin 3, biomarkers, diagnosis, prognosis | Rev Cardiovasc Med | 2026 | 0 |
| New pharmacologic and interventional horizons in hypertension and nondialysis chronic kidney disease: bridging innovation and clinical translation. PMID 42775984 — kidney diseases, hypertension, aldosterone, blood pressure, kidney, antibodies, monoclonal, blood pressure monitoring, ambulatory, natriuretic peptides, therapeutics, endothelin receptor antagonists, mineralocorticoid receptor antagonists, thiazides | J Hypertens | 2026 | 0 |
LeadR Networks
Main global connection map